Delivery Order SPE2DR25D3304-SPE2DR26F48G9
- Not listed
- The Defense Logistics Agency awarded a $6,425.86 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical supply procurement from the company's existing indefinite delivery contract with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Yuvafem 10 MCG vaginal insert (18-count) under a firm fixed-price contract with a ceiling value of $1,240.42. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of January 5, 2026. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.36 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 7, 2026, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count) with a ceiling value of $3,694.08 under a firm fixed price contract. This non-set-aside delivery order, with an ultimate completion date of November 17, 2025, represents a purchase of pharmaceutical products to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Yuvafem 10 MCG Vaginal Insert (8-count package) with a contract ceiling value of $1,942.13. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yuvafem 10 MCG vaginal inserts (18-count units) with a ceiling value of $3,966.96. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and requires completion by September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action...
- The Defense Logistics Agency awarded a delivery order valued at $1,214.16 to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Yuvafem 10 micrograms vaginal inserts (8-count package). This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, to be performed at the contractor's Conshohocken, Pennsylvania location. The award was not set-aside and was competitively awarded, demonstrating the contractor's capability to meet federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,803.36 delivery order on December 30, 2025, for Yuvafem 10 mcg vaginal inserts (18 units). This is a firm fixed-price, non-set-aside contract with a completion date of December 31, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,160.76 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Yuvafem 10 microgram vaginal inserts (18 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 12, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,352.04 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48G9Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 8, 2026, for Yuvafem 10 microgram vaginal inserts (18-count package) with a ceiling value of $1,023.26. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The delivery order award demonstrates the company's ongoing role as a critical pharmaceutical distributor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/7/26 |